Skip to main content
Top
Published in: Current Pulmonology Reports 4/2014

01-12-2014 | Interstitial Lung Disease (G. Tino, Section Editor)

Fibrotic hypersensitivity pneumonitis

Authors: Evans R. Fernández Pérez, Kevin K. Brown

Published in: Current Pulmonology Reports | Issue 4/2014

Login to get access

Abstract

Fibrotic hypersensitivity pneumonitis (FHP) is a specific form of HP defined by chest imaging evidence or pathologic evidence of fibrosis or scarring. Fibrotic HP appears to be irreversible, is often progressive and frequently indistinguishable from other forms of chronic fibrosing interstitial lung diseases (ILD), in particular idiopathic pulmonary fibrosis (IPF). Accurate diagnosis is a challenge given the diverse and often nonspecific clinicoradiologic patterns, heterogenous clinical course, and a frequent lack of a readily recognizable temporal relationship between exposure to an inciting antigen (IA) and symptoms in more than half of the patients. This chapter focuses on the clinical features, diagnostic evaluation and management of FHP.
Literature
1.
go back to reference Monkare S, Haahtela T. Farmer's lung–a 5-year follow-up of eighty-six patients. Clin Allergy. 1987;17:143–51.PubMedCrossRef Monkare S, Haahtela T. Farmer's lung–a 5-year follow-up of eighty-six patients. Clin Allergy. 1987;17:143–51.PubMedCrossRef
2.
go back to reference Monkare S, Ikonen M, Haahtela T. Radiologic findings in farmer's lung. Prognosis and correlation to lung function. Chest. 1985;87:460–6.PubMedCrossRef Monkare S, Ikonen M, Haahtela T. Radiologic findings in farmer's lung. Prognosis and correlation to lung function. Chest. 1985;87:460–6.PubMedCrossRef
3.••
go back to reference Fernandez Perez ER, Swigris JJ, Forssen AV, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144:1644–51. This study assesses the prognostic impact of antigen exposure in patients with chronic hypersensitivity pneumonitis.PubMedCrossRef Fernandez Perez ER, Swigris JJ, Forssen AV, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144:1644–51. This study assesses the prognostic impact of antigen exposure in patients with chronic hypersensitivity pneumonitis.PubMedCrossRef
4.
go back to reference Vourlekis JS, Schwarz MI, Cherniack RM, et al. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med. 2004;116:662–8.PubMedCrossRef Vourlekis JS, Schwarz MI, Cherniack RM, et al. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med. 2004;116:662–8.PubMedCrossRef
5.
go back to reference Sahin H, Brown KK, Curran-Everett D, et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology. 2007;244:591–8.PubMedCrossRef Sahin H, Brown KK, Curran-Everett D, et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology. 2007;244:591–8.PubMedCrossRef
6.
go back to reference Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc. 2007;82:812–6.PubMedCrossRef Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc. 2007;82:812–6.PubMedCrossRef
7.
go back to reference Hanak V, Golbin JM, Hartman TE, Ryu JH. High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. Chest. 2008;134:133–8.PubMedCrossRef Hanak V, Golbin JM, Hartman TE, Ryu JH. High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. Chest. 2008;134:133–8.PubMedCrossRef
8.
go back to reference Okamoto T, Miyazaki Y, Ogura T, et al. A nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan. Respir Investig. 2013;51:191–9.PubMedCrossRef Okamoto T, Miyazaki Y, Ogura T, et al. A nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan. Respir Investig. 2013;51:191–9.PubMedCrossRef
9.
go back to reference Takemura T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med. 2008;14:440–54.PubMedCrossRef Takemura T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med. 2008;14:440–54.PubMedCrossRef
10.
go back to reference Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol. 2008;83:237–44.PubMedCrossRef Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol. 2008;83:237–44.PubMedCrossRef
11.
go back to reference Arras M, Huaux F, Vink A, et al. Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol. 2001;24:368–75.PubMedCrossRef Arras M, Huaux F, Vink A, et al. Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol. 2001;24:368–75.PubMedCrossRef
12.
go back to reference Gasse P, Riteau N, Vacher R, et al. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS ONE. 2011;6:e23185.PubMedCentralPubMedCrossRef Gasse P, Riteau N, Vacher R, et al. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS ONE. 2011;6:e23185.PubMedCentralPubMedCrossRef
13.
go back to reference Simonian PL, Wehrmann F, Roark CL, Born WK, O'Brien RL, Fontenot AP. gammadelta T cells protect against lung fibrosis via IL-22. J Exp Med. 2010;207:2239–53.PubMedCentralPubMedCrossRef Simonian PL, Wehrmann F, Roark CL, Born WK, O'Brien RL, Fontenot AP. gammadelta T cells protect against lung fibrosis via IL-22. J Exp Med. 2010;207:2239–53.PubMedCentralPubMedCrossRef
14.
go back to reference Kiwamoto T, Ishii Y, Morishima Y, et al. Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am J Respir Crit Care Med. 2006;174:142–51.PubMedCrossRef Kiwamoto T, Ishii Y, Morishima Y, et al. Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am J Respir Crit Care Med. 2006;174:142–51.PubMedCrossRef
15.
go back to reference Boveda-Ruiz D, D'Alessandro-Gabazza CN, Toda M, et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. Immunobiology. 2013;218:245–54.PubMedCrossRef Boveda-Ruiz D, D'Alessandro-Gabazza CN, Toda M, et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. Immunobiology. 2013;218:245–54.PubMedCrossRef
16.
go back to reference Liu F, Liu J, Weng D, et al. CD4 + CD25 + Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS ONE. 2010;5:e15404.PubMedCentralPubMedCrossRef Liu F, Liu J, Weng D, et al. CD4 + CD25 + Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS ONE. 2010;5:e15404.PubMedCentralPubMedCrossRef
17.
go back to reference Hao Z, Hampel B, Yagita H, Rajewsky K. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med. 2004;199:1355–65.PubMedCentralPubMedCrossRef Hao Z, Hampel B, Yagita H, Rajewsky K. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med. 2004;199:1355–65.PubMedCentralPubMedCrossRef
18.
19.
go back to reference Jinta T, Miyazaki Y, Kishi M, et al. The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers. Am J Clin Pathol. 2010;134:613–20.PubMedCrossRef Jinta T, Miyazaki Y, Kishi M, et al. The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers. Am J Clin Pathol. 2010;134:613–20.PubMedCrossRef
20.•
go back to reference Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2006;173:188–98. This study underscores the value of gene expression signature differences between IPF and HP.PubMedCentralPubMedCrossRef Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2006;173:188–98. This study underscores the value of gene expression signature differences between IPF and HP.PubMedCentralPubMedCrossRef
21.
go back to reference Morell F, Villar A, Montero MA, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med. 2013;1:685–94.PubMedCrossRef Morell F, Villar A, Montero MA, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med. 2013;1:685–94.PubMedCrossRef
22.
go back to reference Mooney JJ, Elicker BM, Urbania TH, et al. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest. 2013;144:586–92.PubMedCrossRef Mooney JJ, Elicker BM, Urbania TH, et al. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest. 2013;144:586–92.PubMedCrossRef
23.
go back to reference Okamoto T, Miyazaki Y, Tomita M, Tamaoka M, Inase N. A familial history of pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis. Respiration. 2013;85:384–90.PubMedCrossRef Okamoto T, Miyazaki Y, Tomita M, Tamaoka M, Inase N. A familial history of pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis. Respiration. 2013;85:384–90.PubMedCrossRef
24.
25.
go back to reference Wahlstrom J, Berlin M, Lundgren R, et al. Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J. 1997;10:772–9.PubMed Wahlstrom J, Berlin M, Lundgren R, et al. Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J. 1997;10:772–9.PubMed
26.
go back to reference Makimoto N, Kajimoto K, Inoki A, et al. Familial outbreak with hypersensitivity pneumonitis. Nihon Naika Gakkai Zasshi. 1991;80:1132–3.PubMedCrossRef Makimoto N, Kajimoto K, Inoki A, et al. Familial outbreak with hypersensitivity pneumonitis. Nihon Naika Gakkai Zasshi. 1991;80:1132–3.PubMedCrossRef
27.
go back to reference Camarena A, Juarez A, Mejia M, et al. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med. 2001;163:1528–33.PubMedCrossRef Camarena A, Juarez A, Mejia M, et al. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med. 2001;163:1528–33.PubMedCrossRef
28.
go back to reference Ando M, Hirayama K, Soda K, Okubo R, Araki S, Sasazuki T. HLA-DQw3 in Japanese summer-type hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am Rev Respir Dis. 1989;140:948–50.PubMedCrossRef Ando M, Hirayama K, Soda K, Okubo R, Araki S, Sasazuki T. HLA-DQw3 in Japanese summer-type hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am Rev Respir Dis. 1989;140:948–50.PubMedCrossRef
29.
go back to reference Haslam PL, Parker DJ, Townsend PJ. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis. Chest. 1990;97:651–61.PubMedCrossRef Haslam PL, Parker DJ, Townsend PJ. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis. Chest. 1990;97:651–61.PubMedCrossRef
30.
go back to reference Aquino-Galvez A, Camarena A, Montano M, et al. Transporter associated with antigen processing (TAP) 1 gene polymorphisms in patients with hypersensitivity pneumonitis. Exp Mol Pathol. 2008;84:173–7.PubMedCrossRef Aquino-Galvez A, Camarena A, Montano M, et al. Transporter associated with antigen processing (TAP) 1 gene polymorphisms in patients with hypersensitivity pneumonitis. Exp Mol Pathol. 2008;84:173–7.PubMedCrossRef
31.
32.
go back to reference Ohtsuka Y, Munakata M, Tanimura K, et al. Smoking promotes insidious and chronic farmer's lung disease, and deteriorates the clinical outcome. Intern Med. 1995;34:966–71.PubMedCrossRef Ohtsuka Y, Munakata M, Tanimura K, et al. Smoking promotes insidious and chronic farmer's lung disease, and deteriorates the clinical outcome. Intern Med. 1995;34:966–71.PubMedCrossRef
33.
go back to reference Koschel DS, Cardoso C, Wiedemann B, Hoffken G, Halank M. Pulmonary hypertension in chronic hypersensitivity pneumonitis. Lung. 2012;190:295–302.PubMedCrossRef Koschel DS, Cardoso C, Wiedemann B, Hoffken G, Halank M. Pulmonary hypertension in chronic hypersensitivity pneumonitis. Lung. 2012;190:295–302.PubMedCrossRef
34.
go back to reference Gudmundsson G, Monick MM, Hunninghake GW. Viral infection modulates expression of hypersensitivity pneumonitis. J Immunol. 1999;162:7397–401.PubMed Gudmundsson G, Monick MM, Hunninghake GW. Viral infection modulates expression of hypersensitivity pneumonitis. J Immunol. 1999;162:7397–401.PubMed
35.
go back to reference Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.PubMedCrossRef Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.PubMedCrossRef
36.
go back to reference Lubin M, Chen H, Elicker B, Jones KD, Collard HR, Lee JS. A Comparison of Health-Related Quality of Life in Idiopathic Pulmonary Fibrosis and Chronic Hypersensitivity Pneumonitis. Chest 2014. Lubin M, Chen H, Elicker B, Jones KD, Collard HR, Lee JS. A Comparison of Health-Related Quality of Life in Idiopathic Pulmonary Fibrosis and Chronic Hypersensitivity Pneumonitis. Chest 2014.
37.
go back to reference Olson AL, Huie TJ, Groshong SD, et al. Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series. Chest. 2008;134:844–50.PubMedCrossRef Olson AL, Huie TJ, Groshong SD, et al. Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series. Chest. 2008;134:844–50.PubMedCrossRef
38.
go back to reference Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733–48.PubMedCrossRef Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733–48.PubMedCrossRef
40.
go back to reference Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax. 2005;60:665–71.PubMedCentralPubMedCrossRef Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax. 2005;60:665–71.PubMedCentralPubMedCrossRef
41.
go back to reference Silva CI, Muller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008;246:288–97.PubMedCrossRef Silva CI, Muller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008;246:288–97.PubMedCrossRef
42.
go back to reference Nishiyama O, Taniguchi H, Kondoh Y, et al. Familial idiopathic pulmonary fibrosis: serial high-resolution computed tomography findings in 9 patients. J Comput Assist Tomogr. 2004;28:443–8.PubMedCrossRef Nishiyama O, Taniguchi H, Kondoh Y, et al. Familial idiopathic pulmonary fibrosis: serial high-resolution computed tomography findings in 9 patients. J Comput Assist Tomogr. 2004;28:443–8.PubMedCrossRef
43.
go back to reference Jeong YJ, Lee KS, Chung MP, Han J, Johkoh T, Ichikado K. Chronic hypersensitivity pneumonitis and pulmonary sarcoidosis: differentiation from usual interstitial pneumonia using high-resolution computed tomography. Semin Ultrasound CT MR. 2014;35:47–58.PubMedCrossRef Jeong YJ, Lee KS, Chung MP, Han J, Johkoh T, Ichikado K. Chronic hypersensitivity pneumonitis and pulmonary sarcoidosis: differentiation from usual interstitial pneumonia using high-resolution computed tomography. Semin Ultrasound CT MR. 2014;35:47–58.PubMedCrossRef
44.
go back to reference Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012;40:377–85.PubMedCrossRef Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012;40:377–85.PubMedCrossRef
45.•
go back to reference Lynch DA, Newell JD, Logan PM, King Jr TE, Muller NL. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol. 1995;165:807–11. This study describes the HRCT features that best differentiate CHP from NSIP and IPF.PubMedCrossRef Lynch DA, Newell JD, Logan PM, King Jr TE, Muller NL. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol. 1995;165:807–11. This study describes the HRCT features that best differentiate CHP from NSIP and IPF.PubMedCrossRef
47.
go back to reference Fenoglio CM, Reboux G, Sudre B, et al. Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J. 2007;29:706–12.PubMedCrossRef Fenoglio CM, Reboux G, Sudre B, et al. Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J. 2007;29:706–12.PubMedCrossRef
48.
go back to reference Cormier Y, Belanger J, Durand P. Factors influencing the development of serum precipitins to farmer's lung antigen in Quebec dairy farmers. Thorax. 1985;40:138–42.PubMedCentralPubMedCrossRef Cormier Y, Belanger J, Durand P. Factors influencing the development of serum precipitins to farmer's lung antigen in Quebec dairy farmers. Thorax. 1985;40:138–42.PubMedCentralPubMedCrossRef
49.
go back to reference Fink JN, Ortega HG, Reynolds HY, et al. Needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2005;171:792–8.PubMedCrossRef Fink JN, Ortega HG, Reynolds HY, et al. Needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2005;171:792–8.PubMedCrossRef
50.
go back to reference Dalphin JC, Toson B, Monnet E, et al. Farmer's lung precipitins in Doubs (a department of France): prevalence and diagnostic value. Allergy. 1994;49:744–50.PubMedCrossRef Dalphin JC, Toson B, Monnet E, et al. Farmer's lung precipitins in Doubs (a department of France): prevalence and diagnostic value. Allergy. 1994;49:744–50.PubMedCrossRef
51.
go back to reference Nademi Z, Todryk S, Baldwin C. Characteristics of antibody responses in Pigeon Fanciers’ Lung. Mol Immunol. 2013;54:227–32.PubMedCrossRef Nademi Z, Todryk S, Baldwin C. Characteristics of antibody responses in Pigeon Fanciers’ Lung. Mol Immunol. 2013;54:227–32.PubMedCrossRef
52.
go back to reference McSharry C, Dye GM, Ismail T, Anderson K, Spiers EM, Boyd G. Quantifying serum antibody in bird fanciers' hypersensitivity pneumonitis. BMC Pulm Med. 2006;6:16.PubMedCentralPubMedCrossRef McSharry C, Dye GM, Ismail T, Anderson K, Spiers EM, Boyd G. Quantifying serum antibody in bird fanciers' hypersensitivity pneumonitis. BMC Pulm Med. 2006;6:16.PubMedCentralPubMedCrossRef
53.
go back to reference Ohtani Y, Kojima K, Sumi Y, et al. Inhalation provocation tests in chronic bird fancier's lung. Chest. 2000;118:1382–9.PubMedCrossRef Ohtani Y, Kojima K, Sumi Y, et al. Inhalation provocation tests in chronic bird fancier's lung. Chest. 2000;118:1382–9.PubMedCrossRef
54.
go back to reference Ramirez-Venegas A, Sansores RH, Perez-Padilla R, Carrillo G, Selman M. Utility of a provocation test for diagnosis of chronic pigeon Breeder's disease. Am J Respir Crit Care Med. 1998;158:862–9.PubMedCrossRef Ramirez-Venegas A, Sansores RH, Perez-Padilla R, Carrillo G, Selman M. Utility of a provocation test for diagnosis of chronic pigeon Breeder's disease. Am J Respir Crit Care Med. 1998;158:862–9.PubMedCrossRef
55.
go back to reference Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting Survival Across Chronic Interstitial Lung Disease: The ILD-GAP Model. Chest. 2014;145:723–8.PubMedCrossRef Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting Survival Across Chronic Interstitial Lung Disease: The ILD-GAP Model. Chest. 2014;145:723–8.PubMedCrossRef
56.
go back to reference Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004–14.PubMedCrossRef Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004–14.PubMedCrossRef
57.
go back to reference Gaxiola M, Buendia-Roldan I, Mejia M, et al. Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival. Respir Med. 2011;105:608–14.PubMedCrossRef Gaxiola M, Buendia-Roldan I, Mejia M, et al. Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival. Respir Med. 2011;105:608–14.PubMedCrossRef
58.
go back to reference Ohshimo S, Bonella F, Cui A, et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179:1043–7.PubMedCrossRef Ohshimo S, Bonella F, Cui A, et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179:1043–7.PubMedCrossRef
59.
go back to reference Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2006;30:201–8.PubMedCrossRef Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2006;30:201–8.PubMedCrossRef
60.
go back to reference Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009;33:1765–70.PubMedCrossRef Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009;33:1765–70.PubMedCrossRef
61.
go back to reference Kuramochi J, Inase N, Takayama K, Miyazaki Y, Yoshizawa Y. Detection of indoor and outdoor avian antigen in management of bird-related hypersensitivity pneumonitis. Allergol Int. 2010;59:223–8.PubMedCrossRef Kuramochi J, Inase N, Takayama K, Miyazaki Y, Yoshizawa Y. Detection of indoor and outdoor avian antigen in management of bird-related hypersensitivity pneumonitis. Allergol Int. 2010;59:223–8.PubMedCrossRef
62.
go back to reference Craig TJ, Hershey J, Engler RJ, Davis W, Carpenter GB, Salata K. Bird antigen persistence in the home environment after removal of the bird. Ann Allergy. 1992;69:510–2.PubMed Craig TJ, Hershey J, Engler RJ, Davis W, Carpenter GB, Salata K. Bird antigen persistence in the home environment after removal of the bird. Ann Allergy. 1992;69:510–2.PubMed
Metadata
Title
Fibrotic hypersensitivity pneumonitis
Authors
Evans R. Fernández Pérez
Kevin K. Brown
Publication date
01-12-2014
Publisher
Springer US
Published in
Current Pulmonology Reports / Issue 4/2014
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-014-0094-0

Other articles of this Issue 4/2014

Current Pulmonology Reports 4/2014 Go to the issue

Respiratory Infections (C Daley, Section Editor)

Pulmonary fungal infections- recent updates

Mediastinal Diseases (D. Hsia, Section Editor)

Primary mediastinal B-cell lymphoma

Smoking Cessation (S Veeraraghavan, Section Editor)

Electronic nicotine delivery systems for smoking cessation: where are we?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.